ARTL vs PTC · $15.6M cap vs P/E 48, rev $2.74B
Artelo Biosciences Inc (ARTL) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Artelo Biosciences Inc (ARTL) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
ARTL does not have a complete income-statement cache yet.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
ARTL currently screens at market cap $15.6M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the ARTL and PTC stock pages for the full models.
Not investment advice.